Regular Article
Demonstration of Activin-A in Arteriosclerotic Lesions

https://doi.org/10.1006/bbrc.1994.2685Get rights and content

Abstract

We previously reported that follistatin, an activin-binding protein, is produced in arteriosclerotic lesions. Here, the expression of activin-A which promotes the growth of vascular smooth muscle cells was examined in arteriosclerotic lesions of WHHL (Watanabe heritable hyperlipidemic) rabbits. Activin-A mRNA was detected in normal aorta by reverse transcriptase-polymerase chain reaction using specific primers for activin-A cDNA and was increased remarkably in arteriosclerotic lesions. In addition, using the cloned rabbit activin-A cDNA, RNA probe was prepared and in situ hybridization histochemistry was performed. Activin-A transcripts were detected abundantly in neointima of the diseased artery. Furthermore, immunohistochemistry also detected activin-A at the protein level. These observations suggest that activin-A is a cytokine expressed in arteriosclerotic lesions and might be involved in the pathogenesis of atherosclerosis.

References (0)

Cited by (31)

  • Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients

    2011, Journal of Neuroimmunology
    Citation Excerpt :

    In addition to peripheral immune cells, other potential cellular sources are vascular smooth muscle cells (Inoue et al., 1993) as well as vascular endothelial cells (Michel et al., 1996), chondrocytes and osteoblasts of developing bone, cells that are located in the ovary, the testis, the pituitary gland, the liver, the prostate gland, the pancreas and the kidney (Phillips and de Kretser, 1998). Therefore, follistatin in the serum was found to play a role is several processes, such as in atherogenic growth (Inoue et al., 1993; Inoue et al., 1994), in angiogenesis (Kozian et al., 1997) and in bone formation via its binding to activin or BMPs or serum α2-macroglobulin (Phillips et al., 1997). Since there is an immune infiltration to the active CNS lesions in MS and since BMPs were found to be expressed in those lesions (Deininger et al., 1995), we examined the neurogenic potential of immune cells in MS by measuring the follistatin production by immune cells.

  • The activin/inhibin family

    2003, The Cytokine Handbook
  • Follistatin: A multifunctional regulatory protein

    1998, Frontiers in Neuroendocrinology
View all citing articles on Scopus
View full text